Companies · AI / ML
ST. PETERSBURG · CA, USA; Remote · AI / ML · refined from filed group “Other Technology” · founded 2017 · https://www.provenskincare.com
Diligence memoA one-page analyst read on PROVEN Group, Inc. — recommendation, valuation, rhythm, risks.→PROVEN Group, Inc. looks fair against its niche peers and is dormant on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the ai/ml sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
PROVEN Group, Inc. is one of 2067 AI / ML companies tracked from ST. PETERSBURG, CA, USA; Remote, on record since 2017. By capital raised it ranks in the upper tier (ahead of 89% of sector peers), and among the largest by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
AI analyst read est. — model-extracted from this company's public description, not a verified fact. 30%
operates a technology-led product inferred from public copy
Grounded in: “You are a venture analyst”
PROVEN is using AI, data and personalization to disrupt CPG
Proven is a data powered skincare company that creates personalized skincare products based on more than 47 factors about an individual's skin, genetic background, lifestyle and environment. Our formulations are rooted in the largest beauty database in the world, the proprietary Skin Genome Project, built in-house by Proven's cofounder Amy Yuan, a computational physicist from Stanford. The database has won MIT's AI Technology of the Year award and encompasses more than 20Million consumer datapoints and thousands of scientific articles on skin. Our challenge now is to tell the story of Proven, and share our industry leading personalized skincare products with the world.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed, Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 33%.
Round size and date are reported; the stage label is inferred from round size (latest is Series A — a $4.0M–$15M round). Valuation is modeled from stage benchmarks scaled by the ai/ml sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 2067 companies in AI / ML. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 89% of sector peers (real $). Modeled value above 93% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Series A) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #18 of 48.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| TARA Intelligence Inc. | Series A | $12.6M | $455.2M | 2.26× |
| Castle Intelligence, Inc. | Series A | $11.7M | $423.4M | 2.10× |
| CrowdAI, Inc. | Series A | $10.1M | $365.0M | 1.81× |
| Socrates AI, Inc. | Series A | $21.0M | $361.3M | 1.79× |
| Roger.ai, Inc. | Series A | $9.6M | $346.3M | 1.72× |
| Cohort Intelligence Corp | Series A | $11.5M | $341.6M | 1.70× |
| Superb AI, Inc. | Series A | $11.5M | $328.6M | 1.63× |
| Intelligencia Inc. | Series A | $13.8M | $304.2M | 1.51× |
| Clearview AI, Inc. | Series A | $8.6M | $299.1M | 1.48× |
| Resistant Ai, Inc. | Series A | $12.5M | $293.9M | 1.46× |
| Sila Inc. | Series A | $10.7M | $279.7M | 1.39× |
| Root AI, Inc. | Series A | $7.9M | $275.8M | 1.37× |
| PROVEN Group, Inc. this company | Series A | $11.9M | $238.8M | 1.19× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Series A | $11.9M | 2021-10-26 | $54.3M | $238.8M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Akash Bedi | — | 1 other | 2021-10 |
| LUKE WESTON | — | — | 2021-10 |
| MINGSHU ZHAO | — | — | 2021-10 |
| ZAOSHI YUAN | — | — | 2021-10 |
PROVEN Group, Inc. is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| Pokee Ai Inc. | AI / ML | Series A | $11.9M | $47.7M | same sector · same stage |
| AirTap AI Inc. | AI / ML | Series A | $12.0M | $42.5M | same sector · same stage |
| Tycho AI Inc. | AI / ML | Series A | $11.8M | $42.1M | same sector · same stage |
| Cyvatar.ai Inc. | AI / ML | Series A | $11.7M | $210.4M | same sector · same stage |
| Castle Intelligence, Inc. | AI / ML | Series A | $11.7M | $423.4M | same sector · same stage |
| Togal.AI, Inc. | AI / ML | Series A | $12.2M | $83.5M | same sector · same stage |
| Cortex Building Intelligence, Inc. | AI / ML | Series A | $11.6M | $165.3M | same sector · same stage |
| Intelligems, Inc. | AI / ML | Series A | $11.5M | $52.9M | same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| Proven Software, Inc. | Software / Tech | Seed | $12.3M | 77% |
| MDalgorithms Inc. Democratizing Dermatology with AI | AI / ML | — | — | 75% |
| Credible Data, Inc. | Software / Tech | Series A | $30.2M | 74% |
| PropRise The AI platform for CRE investment teams | Insurance | — | — | 74% |
| AiPrise AI-powered Global Compliance Platform | Fintech | — | — | 73% |
| BioStack Platforms Real world training envs for healthcare AI models | Pharma | — | — | 72% |
| Provention Bio, Inc. | Biotechnology | Series B | $1.1B | 72% |
| Curebase, Inc. Modern, AI-powered clinical trial software platform. | AI / ML | Series B | $468.5M | 72% |
See where PROVEN Group, Inc. sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at PROVEN Group, Inc., claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.